The post DeFi Projects Show Massive TVL Growth, $USDAI, $STG, and $ASTER Take Charge appeared on BitcoinEthereumNews.com. The decentralized finance (DeFi) sector has experienced notable growth in total value locked (TVL) over the past month. In this respect, USDAI ($USDAI), Stargate Finance ($STG), and Aster ($ASTER) have obtained the leading positions in terms of 30-day performances. As per the data from Phoenix Group, the other DeFi players on the monthly top-10 list include M0 ($M0), Avantis ($AVNT), Synthetix ($SNX), Fluid ($FLUID), Maple ($MPL), Euler Finance ($EUL), and Zeus Network ($ZEUS). Hence, the massive monthly performance of the DeFi ecosystem highlights the renewed investor sentiment and potential growth opportunities. TOP PROJECTS BY MONTHLY #TVL GROWTH$USDAI $STG $ASTER #M0 $AVNT $SNX $FLUID $MPL $EUL $ZEUS $RIVER $SPK $NOTE $KMNO $ONDO pic.twitter.com/1ZengqrC5w — PHOENIX – Crypto News & Analytics (@pnxgrp) October 5, 2025 USDAI Dominates DeFi Market in Monthly TVL Growth with a Stunning 361% Rise Specifically, USDAI ($USDAI) has occupied the top position in the case of TVL growth over the past 30 days. Thus, its TVL has jumped by a staggering 361% to reach the $504.7M mark. At the same time, its market cap stands at $534.1M. In addition to this, Stargate Finance ($STG) has surged by 170%, hitting $757.1M in TVL over the past 30 days. Subsequently, Aster ($ASTR) has witnessed a 166% spike, reaching $776.7M when it comes to TVL. The next noteworthy DeFi project on the list is M0 ($M0), claiming a TVL of up to $796.9M after a 152% increase. After that, Avantis ($AVNT) has claimed the 5th spot at $55.6M, accounting for 142% climb. Additionally, Synthetix’s TVL is now sitting at $152.9M as a result of a 76.1% increase over the past month. Zeus Finance Claims 10th Rank on List with 31.4% TVL Increase Over 30 Days Phoenix Group’s list of top DeFi projects adds Fluid ($FLUID) in the 7th position as it… The post DeFi Projects Show Massive TVL Growth, $USDAI, $STG, and $ASTER Take Charge appeared on BitcoinEthereumNews.com. The decentralized finance (DeFi) sector has experienced notable growth in total value locked (TVL) over the past month. In this respect, USDAI ($USDAI), Stargate Finance ($STG), and Aster ($ASTER) have obtained the leading positions in terms of 30-day performances. As per the data from Phoenix Group, the other DeFi players on the monthly top-10 list include M0 ($M0), Avantis ($AVNT), Synthetix ($SNX), Fluid ($FLUID), Maple ($MPL), Euler Finance ($EUL), and Zeus Network ($ZEUS). Hence, the massive monthly performance of the DeFi ecosystem highlights the renewed investor sentiment and potential growth opportunities. TOP PROJECTS BY MONTHLY #TVL GROWTH$USDAI $STG $ASTER #M0 $AVNT $SNX $FLUID $MPL $EUL $ZEUS $RIVER $SPK $NOTE $KMNO $ONDO pic.twitter.com/1ZengqrC5w — PHOENIX – Crypto News & Analytics (@pnxgrp) October 5, 2025 USDAI Dominates DeFi Market in Monthly TVL Growth with a Stunning 361% Rise Specifically, USDAI ($USDAI) has occupied the top position in the case of TVL growth over the past 30 days. Thus, its TVL has jumped by a staggering 361% to reach the $504.7M mark. At the same time, its market cap stands at $534.1M. In addition to this, Stargate Finance ($STG) has surged by 170%, hitting $757.1M in TVL over the past 30 days. Subsequently, Aster ($ASTR) has witnessed a 166% spike, reaching $776.7M when it comes to TVL. The next noteworthy DeFi project on the list is M0 ($M0), claiming a TVL of up to $796.9M after a 152% increase. After that, Avantis ($AVNT) has claimed the 5th spot at $55.6M, accounting for 142% climb. Additionally, Synthetix’s TVL is now sitting at $152.9M as a result of a 76.1% increase over the past month. Zeus Finance Claims 10th Rank on List with 31.4% TVL Increase Over 30 Days Phoenix Group’s list of top DeFi projects adds Fluid ($FLUID) in the 7th position as it…

DeFi Projects Show Massive TVL Growth, $USDAI, $STG, and $ASTER Take Charge

The decentralized finance (DeFi) sector has experienced notable growth in total value locked (TVL) over the past month. In this respect, USDAI ($USDAI), Stargate Finance ($STG), and Aster ($ASTER) have obtained the leading positions in terms of 30-day performances. As per the data from Phoenix Group, the other DeFi players on the monthly top-10 list include M0 ($M0), Avantis ($AVNT), Synthetix ($SNX), Fluid ($FLUID), Maple ($MPL), Euler Finance ($EUL), and Zeus Network ($ZEUS). Hence, the massive monthly performance of the DeFi ecosystem highlights the renewed investor sentiment and potential growth opportunities.

USDAI Dominates DeFi Market in Monthly TVL Growth with a Stunning 361% Rise

Specifically, USDAI ($USDAI) has occupied the top position in the case of TVL growth over the past 30 days. Thus, its TVL has jumped by a staggering 361% to reach the $504.7M mark. At the same time, its market cap stands at $534.1M. In addition to this, Stargate Finance ($STG) has surged by 170%, hitting $757.1M in TVL over the past 30 days.

Subsequently, Aster ($ASTR) has witnessed a 166% spike, reaching $776.7M when it comes to TVL. The next noteworthy DeFi project on the list is M0 ($M0), claiming a TVL of up to $796.9M after a 152% increase. After that, Avantis ($AVNT) has claimed the 5th spot at $55.6M, accounting for 142% climb. Additionally, Synthetix’s TVL is now sitting at $152.9M as a result of a 76.1% increase over the past month.

Zeus Finance Claims 10th Rank on List with 31.4% TVL Increase Over 30 Days

Phoenix Group’s list of top DeFi projects adds Fluid ($FLUID) in the 7th position as it has risen by 53.9% to claim a TVL of almost $2.8B. Following that, Maple’s ($MPL) 33.1% TVL increase has elevated it to $2.8B. Moreover, Euler Finance ($EUL) has touched the 1.9B figure in TVL, led by a 32.2% monthly surge. Coming after that, Zeus Network ($ZEUS) has recorded a 31.4% monthly spike to reach $61.9M in TVL. Overall, amid the wide-scale TVL growth in the DeFi sector, the market onlookers are keenly looking for the signs of the continuation or a reversal of this pattern.

Source: https://blockchainreporter.net/defi-projects-show-massive-tvl-growth-usdai-stg-and-aster-take-charge/

Market Opportunity
DeFi Logo
DeFi Price(DEFI)
$0.000428
$0.000428$0.000428
-6.14%
USD
DeFi (DEFI) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

U.S. President Donald Trump filed a lawsuit against JPMorgan Chase and its CEO Jamie Dimon personally, accusing the institution of deliberate debanking. The politician
Share
Incrypted2026/01/23 15:59
Here’s why Polygon price is at risk of a 25% plunge

Here’s why Polygon price is at risk of a 25% plunge

Polygon price continued its freefall, reaching its lowest level since April 21, as the broader crypto sell-off gained momentum. Polygon (POL) dropped to $0.1915, down 32% from its highest point in May and 74% below its 2024 peak. The crash…
Share
Crypto.news2025/06/19 00:56
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26